UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Physicians Update


Physicians Update

Fall 2010

UCLA Clinical Updates: The Latest Advances

  • UCLA is seeking participants for clinical studies of drugs that show promise in the treatment of myelofibrosis and myelodysplasia. A number of studies at UCLA are currently enrolling patients with these bone marrow disorders.
  • Surgeons treating prostate cancer have moved toward minimally invasive or even ablative procedures, working to minimize or even eliminate the incision needed to treat prostate tumors.
  • UCLA offers the only facility in greater Los Angeles dedicated solely to the diagnosis and treatment of children and adults who suffer from food and drug allergies. Center physicians offer the most up-to-date techniques, including oral food challenges, graded drug challenges, aspirin and other drug desensitization programs, and complete skin testing for penicillin allergy.
  • HDR brachytherapy differs from other forms in that the source of radiation moves within the target under robotic control. Accurate control over both time and location of radiation exposure allows specialists to adapt the shape and strength of the radiation exposure to conform exactly to the tumor target while normal organs are protected.
  • PU Fall 2010-Clinical UpdatesUCLA is among a handful of centers nationwide offering the IBV valve as a Humanitarian Use Device for patients with prolonged air leaks of the lungs. Patients who receive the minimally invasive device suffer fewer complications, need less pain medication and spend fewer days in the hospital than those who undergo other treatments to stop air leaks.
  • The UCLA Pediatric IBD Program offers a full range of expert care and related services to set young patients with inflammatory bowel disease on course to successfully manage their disease.
  • Using an endoscopic endonasal approach to skull-base tumors, performed using the natural pathway of the nasal cavity without need for an incision, surgeons can safely and effectively remove tumors that until recently would have required open craniotomy procedures.
  • The UCLA Division of Cardiothoracic Surgery is among the nation’s leaders in providing care for a wide range of chest disorders. With top-caliber expertise in prevention, detection and treatment, and one of the world’s leading research programs, UCLA not only provides the most advanced therapies, but often defines the leading edge of care.

To download these and other clinical advances at UCLA Health, go to: www.uclahealth.org/clinicalupdates

Add a comment

Please note that we are unable to respond to medical questions through the comments feature below. For information about health care, or if you need help in choosing a UCLA physician, please contact UCLA Physician Referral Service (PRS) at 1-800-UCLA-MD1 (1-800-825-2631) and ask to speak with a referral nurse. Thank you!

comments powered by Disqus